Nitto Avecia at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

Nitto Avecia takes part in 1 session at TIDES Europe 2026 in Amsterdam, and exhibits at Booth 102. Its program compares hybrid enzymatic ligation with chemical ligation. The company makes oligonucleotide drug substance under contract, from early process work to commercial GMP production.

OrganizationTIDES Europe 2026 Attendance
Nitto Avecia
Milford, Massachusetts
avecia.com/Avecia
CDMO & CROSilver sponsor
Contract developer and manufacturer of oligonucleotide APIs, from process development through commercial GMP production.
Booth
Exhibiting at Booth 102
Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm
Talk
Wed Nov 4
16:15–16:45
Hybrid Enzymatic vs. Chemical Ligation
Oligonucleotide Chemistry, Manufacturing & Controls

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Nitto Avecia

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction